Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Urological Cancer Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Urological Cancer Drugs market segmented into
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
Based on the end-use, the global Urological Cancer Drugs market classified into
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Based on geography, the global Urological Cancer Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Tolmar Inc
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL UROLOGICAL CANCER DRUGS INDUSTRY
2.1 Summary about Urological Cancer Drugs Industry
2.2 Urological Cancer Drugs Market Trends
2.2.1 Urological Cancer Drugs Production & Consumption Trends
2.2.2 Urological Cancer Drugs Demand Structure Trends
2.3 Urological Cancer Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Xofigo (Radium Ra 223 Dichloride)
4.2.2 Jevtana (Cabazitaxel)
4.2.3 Inlyta (Axitinib)
4.2.4 Votrient (Pazopanib Hydrochloride)
4.2.5 Sutent (Sunitinib Malate)
4.2.6 Zytiga (Abiraterone Acetate)
4.2.7 Xtandi (Enzalutamide)
4.2.8 Opdivo (Nivolumab)
4.2.9 Provenge (Sipuleucel-T)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Prostate Cancer
4.3.2 Bladder Cancer
4.3.3 Kidney Cancer
4.3.4 Testicular Cancer
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Xofigo (Radium Ra 223 Dichloride)
5.2.2 Jevtana (Cabazitaxel)
5.2.3 Inlyta (Axitinib)
5.2.4 Votrient (Pazopanib Hydrochloride)
5.2.5 Sutent (Sunitinib Malate)
5.2.6 Zytiga (Abiraterone Acetate)
5.2.7 Xtandi (Enzalutamide)
5.2.8 Opdivo (Nivolumab)
5.2.9 Provenge (Sipuleucel-T)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Prostate Cancer
5.3.2 Bladder Cancer
5.3.3 Kidney Cancer
5.3.4 Testicular Cancer
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Xofigo (Radium Ra 223 Dichloride)
6.2.2 Jevtana (Cabazitaxel)
6.2.3 Inlyta (Axitinib)
6.2.4 Votrient (Pazopanib Hydrochloride)
6.2.5 Sutent (Sunitinib Malate)
6.2.6 Zytiga (Abiraterone Acetate)
6.2.7 Xtandi (Enzalutamide)
6.2.8 Opdivo (Nivolumab)
6.2.9 Provenge (Sipuleucel-T)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Prostate Cancer
6.3.2 Bladder Cancer
6.3.3 Kidney Cancer
6.3.4 Testicular Cancer
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Xofigo (Radium Ra 223 Dichloride)
7.2.2 Jevtana (Cabazitaxel)
7.2.3 Inlyta (Axitinib)
7.2.4 Votrient (Pazopanib Hydrochloride)
7.2.5 Sutent (Sunitinib Malate)
7.2.6 Zytiga (Abiraterone Acetate)
7.2.7 Xtandi (Enzalutamide)
7.2.8 Opdivo (Nivolumab)
7.2.9 Provenge (Sipuleucel-T)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Prostate Cancer
7.3.2 Bladder Cancer
7.3.3 Kidney Cancer
7.3.4 Testicular Cancer
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Xofigo (Radium Ra 223 Dichloride)
8.2.2 Jevtana (Cabazitaxel)
8.2.3 Inlyta (Axitinib)
8.2.4 Votrient (Pazopanib Hydrochloride)
8.2.5 Sutent (Sunitinib Malate)
8.2.6 Zytiga (Abiraterone Acetate)
8.2.7 Xtandi (Enzalutamide)
8.2.8 Opdivo (Nivolumab)
8.2.9 Provenge (Sipuleucel-T)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Prostate Cancer
8.3.2 Bladder Cancer
8.3.3 Kidney Cancer
8.3.4 Testicular Cancer
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Xofigo (Radium Ra 223 Dichloride)
9.2.2 Jevtana (Cabazitaxel)
9.2.3 Inlyta (Axitinib)
9.2.4 Votrient (Pazopanib Hydrochloride)
9.2.5 Sutent (Sunitinib Malate)
9.2.6 Zytiga (Abiraterone Acetate)
9.2.7 Xtandi (Enzalutamide)
9.2.8 Opdivo (Nivolumab)
9.2.9 Provenge (Sipuleucel-T)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Prostate Cancer
9.3.2 Bladder Cancer
9.3.3 Kidney Cancer
9.3.4 Testicular Cancer
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novartis
10.1.2 Pfizer
10.1.3 Johnson & Johnson
10.1.4 AstraZeneca
10.1.5 Astellas
10.1.6 Bristol-Myers Squibb
10.1.7 Abbott Laboratories
10.1.8 Celgene Corporation
10.1.9 Dendreon Corporation
10.1.10 Ferring Pharmaceuticals
10.1.11 GlaxoSmithKline
10.1.12 Indevus Pharmaceuticals Inc
10.1.13 Ipsen
10.1.14 Roche Healthcare
10.1.15 Sanofi S.A.
10.1.16 Tolmar Inc
10.2 Urological Cancer Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Novartis
10.2.2 Pfizer
10.2.3 Johnson & Johnson
10.2.4 AstraZeneca
10.2.5 Astellas
10.2.6 Bristol-Myers Squibb
10.2.7 Abbott Laboratories
10.2.8 Celgene Corporation
10.2.9 Dendreon Corporation
10.2.10 Ferring Pharmaceuticals
10.2.11 GlaxoSmithKline
10.2.12 Indevus Pharmaceuticals Inc
10.2.13 Ipsen
10.2.14 Roche Healthcare
10.2.15 Sanofi S.A.
10.2.16 Tolmar Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Urological Cancer Drugs Product Type Overview
Table Urological Cancer Drugs Product Type Market Share List
Table Urological Cancer Drugs Product Type of Major Players
Table Brief Introduction of Novartis
Table Brief Introduction of Pfizer
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Astellas
Table Brief Introduction of Bristol-Myers Squibb
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Celgene Corporation
Table Brief Introduction of Dendreon Corporation
Table Brief Introduction of Ferring Pharmaceuticals
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of Indevus Pharmaceuticals Inc
Table Brief Introduction of Ipsen
Table Brief Introduction of Roche Healthcare
Table Brief Introduction of Sanofi S.A.
Table Brief Introduction of Tolmar Inc
Table Products & Services of Novartis
Table Products & Services of Pfizer
Table Products & Services of Johnson & Johnson
Table Products & Services of AstraZeneca
Table Products & Services of Astellas
Table Products & Services of Bristol-Myers Squibb
Table Products & Services of Abbott Laboratories
Table Products & Services of Celgene Corporation
Table Products & Services of Dendreon Corporation
Table Products & Services of Ferring Pharmaceuticals
Table Products & Services of GlaxoSmithKline
Table Products & Services of Indevus Pharmaceuticals Inc
Table Products & Services of Ipsen
Table Products & Services of Roche Healthcare
Table Products & Services of Sanofi S.A.
Table Products & Services of Tolmar Inc
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Urological Cancer Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Urological Cancer Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Urological Cancer Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Urological Cancer Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Urological Cancer Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Urological Cancer Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Urological Cancer Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Urological Cancer Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Urological Cancer Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Urological Cancer Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Urological Cancer Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xofigo (Radium Ra 223 Dichloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Jevtana (Cabazitaxel) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inlyta (Axitinib) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Votrient (Pazopanib Hydrochloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Sutent (Sunitinib Malate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zytiga (Abiraterone Acetate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xtandi (Enzalutamide) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Opdivo (Nivolumab) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Provenge (Sipuleucel-T) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bladder Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Testicular Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xofigo (Radium Ra 223 Dichloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Jevtana (Cabazitaxel) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inlyta (Axitinib) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Votrient (Pazopanib Hydrochloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Sutent (Sunitinib Malate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zytiga (Abiraterone Acetate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xtandi (Enzalutamide) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Opdivo (Nivolumab) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Provenge (Sipuleucel-T) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bladder Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Testicular Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xofigo (Radium Ra 223 Dichloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Jevtana (Cabazitaxel) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inlyta (Axitinib) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Votrient (Pazopanib Hydrochloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Sutent (Sunitinib Malate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zytiga (Abiraterone Acetate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xtandi (Enzalutamide) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Opdivo (Nivolumab) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Provenge (Sipuleucel-T) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bladder Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Testicular Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xofigo (Radium Ra 223 Dichloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Jevtana (Cabazitaxel) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inlyta (Axitinib) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Votrient (Pazopanib Hydrochloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Sutent (Sunitinib Malate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zytiga (Abiraterone Acetate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xtandi (Enzalutamide) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Opdivo (Nivolumab) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Provenge (Sipuleucel-T) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bladder Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Testicular Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xofigo (Radium Ra 223 Dichloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Jevtana (Cabazitaxel) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inlyta (Axitinib) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Votrient (Pazopanib Hydrochloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Sutent (Sunitinib Malate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zytiga (Abiraterone Acetate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xtandi (Enzalutamide) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Opdivo (Nivolumab) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Provenge (Sipuleucel-T) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bladder Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Testicular Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xofigo (Radium Ra 223 Dichloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Jevtana (Cabazitaxel) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inlyta (Axitinib) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Votrient (Pazopanib Hydrochloride) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Sutent (Sunitinib Malate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zytiga (Abiraterone Acetate) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Xtandi (Enzalutamide) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Opdivo (Nivolumab) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Provenge (Sipuleucel-T) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bladder Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Testicular Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of AstraZeneca 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Astellas 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Bristol-Myers Squibb 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Abbott Laboratories 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Celgene Corporation 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Dendreon Corporation 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Ferring Pharmaceuticals 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Indevus Pharmaceuticals Inc 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Ipsen 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Roche Healthcare 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Sanofi S.A. 2017-2020e
Figure Urological Cancer Drugs Sales Revenue (Million USD) of Tolmar Inc 2017-2020e